Adobe stock photo

Because gastric ulcer treatment can be expensive, researchers continue exploring lower-cost options and alternative formulations that maintain efficacy while improving affordability for horse owners. Studies have evaluated many products, but veterinarians emphasize the importance of using treatments supported by research and combining them with management changes that reduce ulcer risk and recurrence. In this Ask TheHorse Live excerpt, James D. Conway III, DVM, associate director of veterinary technical services with Bimeda, discusses advancements towards a more affordable equine gastric ulcer treatment.

This podcast is an excerpt from our Ask TheHorse Live Q&A, “What You Need to Know About Equine Gastric Ulcers.” Listen to the full recording here.

 

About the Expert:

Picture of James D. Conway III, DVM

James D. Conway III, DVM

James D. Conway III, DVM, is the associate director of veterinary technical services at Bimeda. He previously held the same roles at Dechra Veterinary Products and Contura Vet. Conway has been an industry veterinarian for the past 10 years. Prior to his role in industry, he served as an associate veterinarian at a large regional referral lameness and rehab facility in North Texas. Conway completed an internship at Equine Sports Medicine and Surgery, in Weatherford, Texas, and upon completion started his own lameness and sports medicine practice in the panhandle of Texas and Oklahoma. He is a 2012 graduate of Colorado State University Veterinary School, in Fort Collins, where he was heavily involved with equine stifle and condylar fracture research. Conway's publications on bisphosphonates, the equine stifle ethesis, and medial condylar fractures can be found in Equine Veterinary Education and Equine Veterinary Journal.